These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 8995087

  • 1. Ventricular dysfunction and the risk of stroke after myocardial infarction.
    Loh E, Sutton MS, Wun CC, Rouleau JL, Flaker GC, Gottlieb SS, Lamas GA, Moyé LA, Goldhaber SZ, Pfeffer MA.
    N Engl J Med; 1997 Jan 23; 336(4):251-7. PubMed ID: 8995087
    [Abstract] [Full Text] [Related]

  • 2. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both.
    Solomon SD, Zelenkofske S, McMurray JJ, Finn PV, Velazquez E, Ertl G, Harsanyi A, Rouleau JL, Maggioni A, Kober L, White H, Van de Werf F, Pieper K, Califf RM, Pfeffer MA, Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators.
    N Engl J Med; 2005 Jun 23; 352(25):2581-8. PubMed ID: 15972864
    [Abstract] [Full Text] [Related]

  • 3. Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction.
    Murcia AM, Hennekens CH, Lamas GA, Jiménez-Navarro M, Rouleau JL, Flaker GC, Goldman S, Skali H, Braunwald E, Pfeffer MA.
    Arch Intern Med; 2004 Nov 08; 164(20):2273-9. PubMed ID: 15534166
    [Abstract] [Full Text] [Related]

  • 4. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial.
    Kenchaiah S, Davis BR, Braunwald E, Rouleau JL, Dagenais GR, Sussex B, Steingart RM, Brown EJ, Lamas GA, Gordon D, Bernstein V, Pfeffer MA, Survival and Ventricular Enlargement Trial.
    Am Heart J; 2004 Aug 08; 148(2):356-64. PubMed ID: 15309009
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.
    Maggioni AP, Franzosi MG, Santoro E, White H, Van de Werf F, Tognoni G.
    N Engl J Med; 1992 Jul 02; 327(1):1-6. PubMed ID: 1598096
    [Abstract] [Full Text] [Related]

  • 7. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
    Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, Multicenter Automatic Defibrillator Implantation Trial II Investigators.
    N Engl J Med; 2002 Mar 21; 346(12):877-83. PubMed ID: 11907286
    [Abstract] [Full Text] [Related]

  • 8. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.
    Køber L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, Videbaek J, Cole DS, Auclert L, Pauly NC.
    N Engl J Med; 1995 Dec 21; 333(25):1670-6. PubMed ID: 7477219
    [Abstract] [Full Text] [Related]

  • 9. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
    Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE.
    N Engl J Med; 2005 Mar 31; 352(13):1293-304. PubMed ID: 15753114
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: the Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) study.
    Bloch Thomsen PE, Jons C, Raatikainen MJ, Moerch Joergensen R, Hartikainen J, Virtanen V, Boland J, Anttonen O, Gang UJ, Hoest N, Boersma LV, Platou ES, Becker D, Messier MD, Huikuri HV, Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) Study Group.
    Circulation; 2010 Sep 28; 122(13):1258-64. PubMed ID: 20837897
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction.
    Larose E, Ganz P, Reynolds HG, Dorbala S, Di Carli MF, Brown KA, Kwong RY.
    J Am Coll Cardiol; 2007 Feb 27; 49(8):855-62. PubMed ID: 17320743
    [Abstract] [Full Text] [Related]

  • 18. Importance of infarct-related artery patency for recovery of left ventricular function and late survival after primary angioplasty for acute myocardial infarction.
    Brodie BR, Stuckey TD, Kissling G, Hansen CJ, Weintraub RA, Kelly TA.
    J Am Coll Cardiol; 1996 Aug 27; 28(2):319-25. PubMed ID: 8800104
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction.
    Williams MJ, Odabashian J, Lauer MS, Thomas JD, Marwick TH.
    J Am Coll Cardiol; 1996 Jan 27; 27(1):132-9. PubMed ID: 8522686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.